Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating income | — | — | — | — | -$31.1M | -$42.0M | -$51.0M | -$55.8M | -$52.9M | -$51.4M |
| Net income | -$14.7M | -$13.5M | -$17.3M | -$26.3M | -$26.3M | -$37.9M | -$48.0M | -$47.5M | -$43.0M | -$46.4M |
| EPS (diluted) | -$0.42 | -$0.33 | -$0.39 | -$0.54 | -$0.45 | -$0.54 | -$0.62 | -$0.60 | -$0.52 | -$0.54 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$9.24M | -$9.02M | -$12.6M | -$18.5M | -$21.3M | -$30.4M | -$24.2M | -$27.8M | -$30.8M | -$39.0M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $9.19M | $27.4M | $22.9M | $22.2M | $29.2M | $152M | $149M | $151M | $132M | $103M |
| Total assets | $9.50M | $27.8M | $26.2M | $25.3M | $34.5M | $162M | $153M | $154M | $136M | $104M |
| Total liabilities | $3.19M | $3.58M | — | $5.04M | $7.31M | $10.8M | $10.2M | $12.5M | $15.3M | $8.95M |
| Shareholders' equity | $6.31M | $25.9M | $22.3M | $20.3M | $27.2M | $151M | $142M | $142M | $120M | $94.9M |
| Retained earnings | -$78.0M | -$89.8M | -$107M | -$133M | -$160M | -$198M | -$246M | -$293M | -$336M | -$382M |
| Shares (wtd avg diluted) | 35.2M | 43.3M | 45.9M | 52.7M | 62.0M | 69.8M | 76.9M | 79.8M | 83.5M | 85.3M |
Every figure is extracted from ANAVEX LIFE SCIENCES CORP.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.